Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two ‘Endgame’ Districts in Indonesia Using Micronarrative Surveys
暂无分享,去创建一个
[1] R. Anderson,et al. Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review , 2016, Parasites & Vectors.
[2] N. Alexander. Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination , 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[3] J. Sherchand,et al. Factors determining non-compliance to mass drug administration for lymphatic filariasis elimination in endemic districts of Nepal. , 2014, Journal of Nepal Health Research Council.
[4] K. Ramaiah,et al. Progress and Impact of 13 Years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease , 2014, PLoS neglected tropical diseases.
[5] P. J. Hooper,et al. Assessing Progress in Reducing the At-Risk Population after 13 Years of the Global Programme to Eliminate Lymphatic Filariasis , 2014, PLoS neglected tropical diseases.
[6] B. Babu,et al. Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review. , 2014, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[7] R. Rao,et al. Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation , 2013, PLoS neglected tropical diseases.
[8] G. Weil,et al. A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis , 2013, PLoS neglected tropical diseases.
[9] G. Weil,et al. Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program. , 2013, The American journal of tropical medicine and hygiene.
[10] S. Remadevi,et al. Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination , 2012, Tropical parasitology.
[11] Global programme to eliminate lymphatic filariasis: progress report, 2011. , 2012, Releve epidemiologique hebdomadaire.
[12] P. J. Hooper,et al. The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007) , 2010, PLoS neglected tropical diseases.
[13] Shannon K. McClintock,et al. A Community-Based Study of Factors Associated with Continuing Transmission of Lymphatic Filariasis in Leogane, Haiti , 2010, PLoS neglected tropical diseases.
[14] D. Addiss,et al. Predictors of compliance in mass drug administration for the treatment and prevention of lymphatic filariasis in Leogane, Haiti. , 2008, The American journal of tropical medicine and hygiene.
[15] W. Shannon,et al. The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt. , 2007, The American journal of tropical medicine and hygiene.
[16] N. Karunaweera,et al. Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[17] Eric A Ottesen,et al. Lymphatic filariasis: Treatment, control and elimination. , 2006, Advances in parasitology.
[18] B. Duke,et al. Strategies and tools for the control/elimination of lymphatic filariasis. , 1997, Bulletin of the World Health Organization.
[19] D. Rowe,et al. The Special Programme for Research and Training in Tropical Diseases , 1984 .
[20] R. Henderson,et al. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. , 1982, Bulletin of the World Health Organization.